Editorial on the FDA Report on “Successes and Opportunities in Modeling & Simulation for FDA”
Open Access
- 22 December 2022
- journal article
- editorial
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 51 (1) , 6-9
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- In silico scaling and prioritization of chemical disposition and chemical toxicity of 15,145 organic chemicalsComputational Toxicology, 2018
- Introducing a computational method to estimate and prioritize systemic body exposure of organic chemicals in humans using their physicochemical propertiesComputational Toxicology, 2018
- Incorporation of absorption and metabolism into liver toxicity prediction for phytochemicals: A tiered in silico QSAR approachFood and Chemical Toxicology, 2018
- Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular dockingPLOS ONE, 2018
- Potential Public Health Effects of Reducing Nicotine Levels in Cigarettes in the United StatesNew England Journal of Medicine, 2018
- Geographic exposure risk of variant Creutzfeldt‐Jakob disease in US blood donors: a risk‐ranking model to evaluate alternative donor‐deferral policiesTransfusion, 2017
- Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol AToxicology and Applied Pharmacology, 2015
- Modeling the Potential Effects of New Tobacco Products and Policies: A Dynamic Population Model for Multiple Product Use and HarmPLOS ONE, 2015
- Chemical Structure-Based and Toxicogenomic Models2015
- Prediction and evaluation of route dependent dosimetry of BPA in rats at different life stages using a physiologically based pharmacokinetic modelToxicology and Applied Pharmacology, 2013